NCT00080197View on ClinicalTrials.gov

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

May 31, 2005

Conditions

Breast NeoplasmsMetastases

Interventions

DRUG

E7070

Trial Locations (35)

Unknown

Birmingham

Hoover

Sedona

Denver

Torrington

Fort Myers

Ocoee

Tampa

Chicago

Skokie

Urbana

Indianapolis

Overland Park

Minneapolis

St Louis

Albany

Winston-Salem

Kettering

Oklahoma City

Tulsa

Clairton

Pittsburgh

Wexford

Greenville

Austin

Dallas

Fort Worth

Fredericksburg

Houston

Irving

Tyler

Fairfax

Spokane

Vancouver

Edmonton

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00080197 - Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter